Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-amyloid Protein Deposition in AD Subjects Compared to HC

NCT00544453 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
2
Enrollment
OTHER
Sponsor class

Stopped Preliminary data showed \[123I\] MNI-308 not a useful tool in detection of AD.

Conditions

Interventions

Sponsor

Molecular NeuroImaging